Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals shares fell 10 percent on nearly three times the average daily volume Monday after reporting interim results for ACH-3102, a treatment for Hepatitis C.
Going forward ... (see research report)
Subscribe to News Feeds